- Last sale
- Nov 6, 2026 · -12.09%
- Market cap
- $166.73M
- 77.73M shares
- Filings
- 727
Q3 2026+99.2% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+52.4% FY25 yoy
- $166.73M
- —
- 1.0×
- 8.9×
- -5.76%
- —
Twelve months to Sep 30, 2026 · derived
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $149,157,000 | reported | |
| FY 2024 | 2024-12-31 | $74,890,000 | reported | |
| FY 2023 | 2023-12-31 | $71,348,000 | reported | |
| FY 2022 | 2022-12-31 | $65,206,000 | reported | |
| FY 2021 | 2021-12-31 | $55,312,000 | reported | |
| FY 2020 | 2020-12-31 | $49,244,000 | reported | |
| FY 2019 | 2019-12-31 | $62,656,000 | reported | |
| FY 2018 | 2018-12-31 | $52,776,000 | reported | |
| FY 2017 | 2017-12-31 | $40,433,000 | reported | |
| FY 2016 | 2016-12-31 | $34,228,000 | reported |
Segments
LineFY2025ShareChange
Clinical Services Segment$86.98M58%+1,856.7%
Medical Device Segment$62.18M42%−11.7%
Total$149.16M
Neuronetics, Inc. · CIK 1227636 · Engraved from SEC EDGAR